These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17218063)
1. Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Luvisetto S; Marinelli S; Cobianchi S; Pavone F Neuroscience; 2007 Mar; 145(1):1-4. PubMed ID: 17218063 [TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Marinelli S; Luvisetto S; Cobianchi S; Makuch W; Obara I; Mezzaroma E; Caruso M; Straface E; Przewlocka B; Pavone F Neuroscience; 2010 Nov; 171(1):316-28. PubMed ID: 20826198 [TBL] [Abstract][Full Text] [Related]
3. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain. Sato C; Sakai A; Ikeda Y; Suzuki H; Sakamoto A Anesth Analg; 2008 Jan; 106(1):313-20, table of contents. PubMed ID: 18165597 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ranoux D; Attal N; Morain F; Bouhassira D Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226 [TBL] [Abstract][Full Text] [Related]
7. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model. Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453 [TBL] [Abstract][Full Text] [Related]
8. Sciatic nerve cuffing in mice: a model of sustained neuropathic pain. Benbouzid M; Pallage V; Rajalu M; Waltisperger E; Doridot S; Poisbeau P; Freund-Mercier MJ; Barrot M Eur J Pain; 2008 Jul; 12(5):591-9. PubMed ID: 18006342 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Jolivalt CG; Ramos KM; Herbetsson K; Esch FS; Calcutt NA Pain; 2006 Mar; 121(1-2):14-21. PubMed ID: 16480831 [TBL] [Abstract][Full Text] [Related]
11. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468 [TBL] [Abstract][Full Text] [Related]
12. Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice. Meotti FC; Missau FC; Ferreira J; Pizzolatti MG; Mizuzaki C; Nogueira CW; Santos AR Biochem Pharmacol; 2006 Dec; 72(12):1707-13. PubMed ID: 17070780 [TBL] [Abstract][Full Text] [Related]
13. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948 [TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin. Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662 [TBL] [Abstract][Full Text] [Related]
16. Activation of extracellular signal-regulated kinase in sciatic nerve contributes to neuropathic pain after partial sciatic nerve ligation in mice. Kiguchi N; Maeda T; Kobayashi Y; Fukazawa Y; Kishioka S Anesth Analg; 2009 Oct; 109(4):1305-11. PubMed ID: 19762761 [TBL] [Abstract][Full Text] [Related]
17. Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity. Valsecchi AE; Franchi S; Panerai AE; Sacerdote P; Trovato AE; Colleoni M J Neurochem; 2008 Oct; 107(1):230-40. PubMed ID: 18691380 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy. Daemen MA; Hoogland G; Cijntje JM; Spincemaille GH Neurosci Lett; 2008 Oct; 444(1):112-5. PubMed ID: 18694804 [TBL] [Abstract][Full Text] [Related]
19. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine. Thibault K; Elisabeth B; Sophie D; Claude FZ; Bernard R; Bernard C Eur J Pharmacol; 2008 Dec; 600(1-3):71-7. PubMed ID: 18938155 [TBL] [Abstract][Full Text] [Related]
20. A synthetic kainoid, (2S,3R,4R)-3-carboxymethyl-4-(phenylthio)pyrrolidine-2-carboxylic acid (PSPA-1) serves as a novel anti-allodynic agent for neuropathic pain. Soen M; Minami T; Tatsumi S; Mabuchi T; Furuta K; Maeda M; Suzuki M; Ito S Eur J Pharmacol; 2007 Dec; 575(1-3):75-81. PubMed ID: 17826764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]